Hetero Drugs Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CLOPIDOGREL BISULFATE (FORM-I), with a corresponding US DMF Number 24976.
Remarkably, this DMF maintains an Active status since its submission on May 25, 2011, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 17, 2013, and payment made on February 08, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II